News | 23 August 2011
Skystar Bio-Pharmaceutical, a China-based manufacturer of veterinary medicines and vaccines, has reported net revenue of $10m for the second quarter ended 30 June 2011, compared to $8.26m for the same period in 2010. The company has posted a net income ...
Click on the link to read the full article at Pharmaceutical Business Review
(This link will open in a new window)